COVID-19 in Pediatric Populations
Authors:
- 26 July 2024
- journal article
- research article
- Published by Elsevier in Clinics in Chest Medicine
- Vol. 45 (3) , 675-684
Abstract
No abstract availableKeywords
Funding Information
- National Heart Lung and Blood Institute
- Cystic Fibrosis Foundation
- German Research Foundation
This publication has 80 references indexed in Scilit:
- International Pediatric COVID-19 Severity Over the Course of the PandemicJAMA Pediatrics, 2023
- Assessment of COVID-19 as the Underlying Cause of Death Among Children and Young People Aged 0 to 19 Years in the USJAMA Network Open, 2023
- Clinical Features and Burden of Postacute Sequelae of SARS-CoV-2 Infection in Children and AdolescentsJAMA Pediatrics, 2022
- Neurodevelopmental Outcomes at 1 Year in Infants of Mothers Who Tested Positive for SARS-CoV-2 During PregnancyJAMA Network Open, 2022
- Durability of Anti-Spike Antibodies in Infants After Maternal COVID-19 Vaccination or Natural InfectionJAMA, 2022
- Multisystem Inflammatory Syndrome in Children by COVID-19 Vaccination Status of Adolescents in FranceJAMA, 2021
- Pediatric asthma control during the COVID‐19 pandemic: A systematic review and meta‐analysisPediatric Pulmonology, 2021
- SARS‐CoV‐2 antibodies: IgA correlates with severity of disease in early COVID‐19 infectionJournal of Medical Virology, 2021
- Characteristics and Outcomes of US Children and Adolescents With Multisystem Inflammatory Syndrome in Children (MIS-C) Compared With Severe Acute COVID-19JAMA, 2021
- Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19)JAMA Pediatrics, 2020